Xeris Biopharma Holdings, Inc. (XERS) stock price, financials & research | GoAI

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

64/ 100

GoAI Score

Buy

Valuation

87

Deep Value

Sentiment

50

Mixed

Risk

38

Moderate Risk

Momentum

61

Gaining

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Industry: Biotechnology
Sector: Healthcare
Headquarters: US

Market position

Day range

Current $10.48

$10.08$10.60

52-week range

Current $10.48

$5.25$11.33

Open: $10.15
Previous close: $10.19
Volume: 2.71M
Market cap: 1.81B USD
50-day average: $8.6458; +21.21% above average
200-day average: $7.2736; +44.08% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 1.19B USD
EV / EBITDA: 93.32×
Earnings yield: 0.04%
Free cash flow yield: 2.22%

Profitability & efficiency

Return on equity: 4.05%
Return on assets: 0.14%
Return on invested capital: 8.89%

Financial health

Current ratio: 2.19×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

291.85M USD+43.72%

Operating income

24.9M USD+58.54M USD

Net income

554K USD+55.39M USD

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	291.85M USD	203.07M USD	163.91M USD	110.25M USD	49.59M USD
Cost of goods sold	53.41M USD	36.83M USD	28.65M USD	22.63M USD	13.32M USD
Gross profit	238.43M USD	166.24M USD	135.27M USD	87.61M USD	36.27M USD
Research and development	31.17M USD	25.56M USD	22.34M USD	20.97M USD	25.16M USD
Selling, general, and administrative	182.37M USD	163.48M USD	146.1M USD	137.75M USD	125.72M USD
Operating expenses	213.54M USD	199.88M USD	179.28M USD	169.55M USD	151.43M USD
Interest income	4.74M USD	5.32M USD	4.75M USD	2.58M USD	313K USD
Interest expense	29.08M USD	33.18M USD	26.61M USD	14.1M USD	7.18M USD
Depreciation and amortization	12.16M USD	12.63M USD	13.16M USD	12.67M USD	1.88M USD
Operating income	24.9M USD	−33.65M USD	−44.01M USD	−81.94M USD	−115.16M USD
Net income	554K USD	−54.84M USD	−62.26M USD	−94.66M USD	−122.73M USD

Company facts updated Oct 11, 2026.

Earnings

EPS beat rate: 64%; 7 beats, 4 misses, 0 met estimates
Average EPS surprise: -84.06%; 11 comparable reports
Latest EPS result: -0.18; Estimate 0.01 · Miss by 1582.70%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

XERS peers

Amgen Inc.

AMGN

Amgen Inc.

$414.87

+1.82%

Gilead Sciences, Inc.

GILD

Gilead Sciences, Inc.

$151.17

+2.77%

Intuitive Surgical, Inc.

ISRG

Intuitive Surgical, Inc.

$423.96

+2.06%

Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

$510.08

+1.36%

Sanofi

SNY

Sanofi

$40.07

-0.40%

Moderna, Inc.

MRNA

Moderna, Inc.

$225

+14.21%

ETFs holding XERS

Funds reporting this stock among their holdings, ordered by reported position size.

ETFMarket valueWeightAUMExpense ratioPrice / 1D

iShares Russell 2000 ETF

iShares Russell 2000 ETFIWM45.76M0.06%78.74B USD0.19%$278.94+0.49%

Vanguard Morningstar Total Stock Market ETF

Vanguard Morningstar Total Stock Market ETFVTI43.83M0.00%2.3T USD0.03%$381.94+0.63%

Vanguard Extended Market ETF

Vanguard Extended Market ETFVXF16.95M0.02%95.4B USD0.05%$235+0.80%

iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETFIWO16.06M0.12%13.92B USD0.24%$356.78+0.94%

State Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETFXPH12.4M2.69%461.57M USD0.35%$64.65+1.60%

Fidelity Enhanced Small Cap ETF

Fidelity Enhanced Small Cap ETFFESM11.29M0.17%6.41B USD0.28%$45.46+0.46%

Schwab U.S. Small-Cap ETF

Schwab U.S. Small-Cap ETFSCHA9.9M0.05%21.82B USD0.03%$32.79+0.40%

First Trust Small Cap Growth AlphaDEX Fund

First Trust Small Cap Growth AlphaDEX FundFYC9.38M0.69%1.35B USD0.70%$115.36+1.35%

iShares Russell 2000 ETF

iShares Russell 2000 ETFIWM

Market value: 45.76M
Weight: 0.06%
AUM: 78.74B USD
Expense ratio: 0.19%
Price / 1D: $278.94+0.49%

Vanguard Morningstar Total Stock Market ETF

Vanguard Morningstar Total Stock Market ETFVTI

Market value: 43.83M
Weight: 0.00%
AUM: 2.3T USD
Expense ratio: 0.03%
Price / 1D: $381.94+0.63%

Vanguard Extended Market ETF

Vanguard Extended Market ETFVXF

Market value: 16.95M
Weight: 0.02%
AUM: 95.4B USD
Expense ratio: 0.05%
Price / 1D: $235+0.80%

iShares Russell 2000 Growth ETF

iShares Russell 2000 Growth ETFIWO

Market value: 16.06M
Weight: 0.12%
AUM: 13.92B USD
Expense ratio: 0.24%
Price / 1D: $356.78+0.94%

State Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETFXPH

Market value: 12.4M
Weight: 2.69%
AUM: 461.57M USD
Expense ratio: 0.35%
Price / 1D: $64.65+1.60%

Fidelity Enhanced Small Cap ETF

Fidelity Enhanced Small Cap ETFFESM

Market value: 11.29M
Weight: 0.17%
AUM: 6.41B USD
Expense ratio: 0.28%
Price / 1D: $45.46+0.46%

Schwab U.S. Small-Cap ETF

Schwab U.S. Small-Cap ETFSCHA

Market value: 9.9M
Weight: 0.05%
AUM: 21.82B USD
Expense ratio: 0.03%
Price / 1D: $32.79+0.40%

First Trust Small Cap Growth AlphaDEX Fund

First Trust Small Cap Growth AlphaDEX FundFYC

Market value: 9.38M
Weight: 0.69%
AUM: 1.35B USD
Expense ratio: 0.70%
Price / 1D: $115.36+1.35%

Continue in GoAI

AI-generated and delayed market data for informational and educational purposes only. Not investment advice.